Medicare Enrolled

Dr. Jerry Izu, M.D.

Obstetrics & Gynecology · Santa Clarita, CA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Speaking/Promotional
23206 LYONS AVE STE 112, Santa Clarita, CA 91321
6615162955
In practice since 2006 (19 years)
NPI: 1407928039 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Izu from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Izu? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Izu

Dr. Jerry Izu is an obstetrics & gynecology specialist in Santa Clarita, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Izu performed 90 Medicare services across 86 unique beneficiaries.

Between the years covered by Open Payments, Dr. Izu received a total of $13,549 from 40 pharmaceutical and/or device companies across 237 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in obstetrics & gynecology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Izu is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ 90 Medicare services $13,549 industry payments

Medicare Practice Summary

Medicare Utilization ↗
90
Medicare services
Bottom 49% in CA for obstetrics & gynecology
86
Unique beneficiaries
$73
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~5 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Pelvic and clinical breast exam for cancer screening
A physical examination of the pelvis and breasts to screen for cervical or vaginal cancer. This procedure involves a clinical assessment performed by a healthcare provider.
43 $43 $165
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
19 $74 $125
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
15 $139 $220
Transvaginal pelvic ultrasound
An ultrasound exam using a probe inserted into the vagina to image the uterus, ovaries, fallopian tubes, cervix, and surrounding pelvic structures.
13 $99 $225
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$13,549
Total received (2018-2024)
Avg $1,936/year across 7 years
Top 4% in CA for obstetrics & gynecology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
40
Companies
237
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$8,500 (62.7%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$4,249 (31.4%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$800 (5.9%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$9,477
2023
$813
2022
$770
2021
$791
2020
$438
2019
$495
2018
$765

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
INTUITIVE SURGICAL, INC.
$8,394
MIMEDX Group, Inc.
$800
ABBVIE INC.
$102
Astellas Pharma US Inc
$66
Exeltis, USA Inc.
$36
Organon Llc
$35
PFIZER INC.
$28
SHIELD THERAPEUTICS INC
$15
Top 3 companies account for 98.1% of 2024 payments
All-time payments by company (2018-2024) ›
INTUITIVE SURGICAL, INC.
$8,394
MIMEDX Group, Inc.
$800
ABBVIE INC.
$691
AbbVie Inc.
$555
AbbVie, Inc.
$298
Exeltis, USA Inc.
$296
Allergan Inc.
$241
Avion Pharmaceuticals
$200
AMAG Pharmaceuticals, Inc.
$182
MAYNE PHARMA COMMERCIAL LLC
$175
Myovant Sciences Inc.
$141
Bayer HealthCare Pharmaceuticals Inc.
$126
TherapeuticsMD, Inc.
$124
Sumitomo Pharma America, Inc.
$116
Duchesnay USA Incorporated
$99
Evofem Biosciences, Inc.
$98
Horizon Therapeutics plc
$89
Merck Sharp & Dohme Corporation
$83
PFIZER INC.
$80
Mission Pharmacal Company
$68
Astellas Pharma US Inc
$66
Novum Pharma, LLC
$64
Organon LLC
$50
CooperSurgical, Inc.
$49
Agile Therapeutics, Inc.
$46
Hologic, LLC
$44
Allergan, Inc.
$42
Daiichi Sankyo Inc.
$42
ASCEND Therapeutics US, LLC
$39
Biohaven Pharmaceuticals, Inc.
$36
Organon Llc
$35
Lupin Inc.
$29
MAYNE PHARMA INC.
$27
Zyla Life Sciences, Inc.
$25
Biohaven Pharmaceutical Holding Company Ltd.
$19
Mycovia Pharmaceuticals, Inc.
$17
Mallinckrodt LLC
$17
SHIELD THERAPEUTICS INC
$15
Hologic Sales and Service, LLC
$15
Channel Medsystems, Inc.
$14
Top 3 companies account for 73.0% of all-time payments
Associated products mentioned in payments ›
ACCRUFER · ACESSA PROVU SYSTEM · ANNOVERA · Alcortin A · Balcoltra · COMIRNATY · CitraNatal · CoolSeal Generator · DAVINCI XI · DUEXIS · Da Vinci Surgical System · ESTROGEL · Endosee · FLUENT FLUID MANAGEMENT SYSTEM · IMVEXXY · INJECTAFER · INTRAROSA · Kyleena · LILETTA · LO LOESTRIN FE · Lupron · MAKENA · MYFEMBREE · Mirena · NEXPLANON · NEXTSTELLIS · NURTEC ODT · NUVARING · OFIRMEV · ORIAHNN · ORILISSA · Orilissa · Osphena · Paragard · Phexxi · Prenate Mini · QULIPTA · SLYND · SOLOSEC · SPRIX · Solosec · Twirla · UBRELVY · VYLEESI · Veozah · Vitafol Ultra · Vivjoa
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (63%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in obstetrics & gynecology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 4% for obstetrics & gynecology in CA.

Looking for an obstetrics & gynecology specialist in Santa Clarita?
Compare obstetricians & gynecologists in the Santa Clarita area by procedure volume, costs, and industry payment transparency.
Browse obstetricians & gynecologists nearby

Geographic Context

Obstetricians & gynecologists within 10 mi
601
Per 100K population
6.1
County median income
$87,760
Nearest hospital
HENRY MAYO NEWHALL HOSPITAL
5.4 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Izu is a clinical cardiology specialist, with moderate Medicare volume, with speaking/promotional industry engagement in the top 4% of CA peers, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Izu experienced with pelvic and clinical breast exam for cancer screening?
Based on Medicare claims data, Dr. Izu performed 43 pelvic and clinical breast exam for cancer screening services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Izu receive payments from pharmaceutical companies?
Yes. Dr. Izu received a total of $13,549 from 40 companies across 237 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Izu's costs compare to other obstetricians & gynecologists in Santa Clarita?
Dr. Izu's average Medicare payment per service is $73. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Izu) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →